Press Releases
Company registers stock in 2007 Employee Stock Option Plan with SEC
BETHESDA, MD – 21 November 2007 – Northwest Biotherapeutics, Inc. (AIM:NWBS and NWBT; OTC BB: NWBO), the US-based biotechnology company focused on developing immunotherapy products for cancer, today filed a Registration Statement with the U.S. Securities and Exchange Commission registering stock underlying its 2007 Employee Stock Option Plan.
For further information, please contact:
Northwest Biotherapeutics
Anthony P. Deasey, Chief Financial Officer |
+ 1 240 497 9024 |
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com)
/ Mary-Jane Johnson / Catherine Breen |
+44 (0)20 7466 5000 |
Collins Stewart Europe Limited
Tim Mickley / Adam Cowen |
+44 (0)20 7523 8350 |
|
